China is now facing a growing aging and terminally ill population with many unmet needs for end-of-life care therefore, it is imperative to implement ACP in China. indicator for quality palliative care and endorsed into national health systems by many high-income countries however, it is little known in mainland China. As the only way to explore patients’ living wills, advance care planning (ACP) is an important means to honor patient autonomy and respect their human rights and dignity. Optimum care for patients with a terminal illness is dependent on understanding their values, beliefs, and preferences on end-of-life issues and providing service that meets their preferences. Compared to their provider, patients gave significantly lower estimations of requiring any future therapy (mean score 84.6 vs 74, p<.001) and future chemotherapy (mean score 84.1 vs 69.8, p<.001) and significantly higher estimations of requiring future surgery (mean score 23.3 vs 40, p<.001), achieving remission (mean score 33.5 vs 47.5, p=.009), survival to 1 year (mean score 77.1 vs 86.4, p=.002), and survival to 5 years (mean score 40.5 vs 61.3, p<.001).Īlthough gynecologic oncology providers believe it is important to discuss prognosis and end-of-life care, there are gaps in communication, knowledge, and expectations between providers and ovarian cancer patients. Descriptive statistics were used to categorize survey answers and compare survey answers between patients and providers multivariable logistic regression evaluated patient survey responses.Īll providers (100%) believed treating providers should discuss prognosis and 90% reported having prognostic conversations with patients, compared to 63%, 37%, and 4% of patients who reported discussing prognosis, living wills/advance directives, and palliative care/hospice services, respectively, with their provider. preferences regarding communication about prognosis.Ī prospective cross-sectional survey was delivered to 10 gynecologic oncology providers and 50 adult ovarian cancer patients from November 2015-April 2016 at one institution.

Our primary objective was to compare physician and patient estimates of survival to 6 months, 1 year, and 5 years secondary objectives included comparing provider and patient responses on the likelihood of requiring future treatments and categorizing patient and provider. There is limited data comparing patient and physician expectations regarding ovarian cancer prognosis.

Racial ambiguity vampire diarie